Mitochondrial function is crucial for maintaining cellular metabolism and growth and plays a role in some forms of diabetes. Diabetes mellitus causes much morbidity and mortality for Americans and people worldwide. In addition, it significantly reduces the quality of life and life span of patients that have diabetes. Mitochondrial dysfunction …
Read More »Influence of Intermittent Fasting on Health Outcomes
Data analysis reveals that intermittent fasting has positive health outcomes ranging from weight loss to elimination of metabolic stress.
Read More »Dapagliflozin Gets Nod as a Breakthrough Therapy Designation for CKD
Dapagliflozin (Farxiga®) has been granted U.S. Food and Drug Administration (FDA) Breakthrough Therapy Designation (BTD) for patients with chronic kidney disease (CKD), whether or not they have type 2 diabetes.
Read More »How Low Should Blood Pressure Targets Go?
Should current guidelines lower the blood pressure treatment threshold for increased prevention of CVD?
Read More »Ineffective Cholesterol Treatment in Type 2 Patients
Addressing the gaps in lipoprotein cholesterol (LDL-C) control and statin prescribing among patients with type 2 diabetes.
Read More »Barriers to Weight Loss and Diet After Gestational Diabetes
No differences in the barriers to weight loss and weight loss success were observed between the intermittent (IER) and continuous (CER) dieters.
Read More »Cardiovascular Benefits of SGLT-2 Inhibitors
In addition to clinical trials, does data from a meta-analysis of retrospective cohort studies support the benefits of SGLT-2 inhibitors?
Read More »How To Address Dexamethasone-Induced Hyperglycemia for Patients with Covid-19
Can we reduce mortality with patients with Covid-19 by controlling blood glucose?
Read More »Evaluation of CVD/CKD Risks in Patients with Type 2 Diabetes
Despite being on first-line oral anti-diabetic drug therapy, the risk of developing CVD/CKD in patients with type 2 diabetes remains high.
Read More »Intensive Life Intervention Improves Risks for Type 2 Diabetes Patients
The Look AHEAD trial had dramatic results for patients with T2D and their risk for cardiovascular disease (CVD).
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.